Cargando…

An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy

PURPOSE: Recent studies have shown that a new generation of synthetic agonist of Toll-like receptor (TLR) 9 consisting a 3′-3′-attached structure and a dCp7-deaza-dG dinucultodie shows more potent immunostimulatory effects in both mouse and human than conventional CpG oligonucleotides. Radiation the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Huagang, Liu, Laibin, Yu, Dong, Kandimalla, Ekambar R., Sun, Hui Bin, Agrawal, Sudhir, Guha, Chandan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364192/ https://www.ncbi.nlm.nih.gov/pubmed/22666458 http://dx.doi.org/10.1371/journal.pone.0038111

Ejemplares similares

TLR9 Agonist Protects Mice from Radiation-Induced Gastrointestinal Syndrome
por: Saha, Subhrajit, et al.
Publicado: (2012)

Novel oligodeoxynucleotide agonists of TLR9 containing N(3)-Me-dC or N(1)-Me-dG modifications
por: Putta, Mallikarjuna Reddy, et al.
Publicado: (2006)

Intratumoural immunotherapy: activation of nucleic acid sensing pattern recognition receptors
por: Agrawal, Sudhir, et al.
Publicado: (2019)

Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9
por: Kandimalla, Ekambar R., et al.
Publicado: (2013)

Low Intensity Focused Ultrasound (LOFU)-mediated Acoustic Immune Priming and Ablative Radiation Therapy for in situ Tumor Vaccines
por: Skalina, Karin A., et al.
Publicado: (2019)

In situ immunization of a TLR9 agonist virus-like particle enhances anti-PD1 therapy
por: Cheng, Yinwen, et al.
Publicado: (2020)

TLR3 and TLR9 Agonists Improve Postexposure Vaccination Efficacy of Live Smallpox Vaccines
por: Israely, Tomer, et al.
Publicado: (2014)

Bone Marrow Stromal Cell Transplantation Mitigates Radiation-Induced Gastrointestinal Syndrome in Mice
por: Saha, Subhrajit, et al.
Publicado: (2011)

Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity
por: Younes, Ahmed I., et al.
Publicado: (2020)

Enhanced systemic tumor suppression by in situ vaccine combining radiation and OX40 agonist with CpG therapy
por: Sun, Zhichen, et al.
Publicado: (2023)

The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer
por: Demaria, Sandra, et al.
Publicado: (2013)

Trial watch: TLR3 agonists in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2020)

TLR Agonist Therapy of Metastatic Breast Cancer in Mice
por: Klinman, Dennis M., et al.
Publicado: (2023)

Integrative Metabolic Signatures for Hepatic Radiation Injury
por: Kurland, Irwin Jack, et al.
Publicado: (2015)

Comparison of human B cell activation by TLR7 and TLR9 agonists
por: Hanten, John A, et al.
Publicado: (2008)

Injection Route and TLR9 Agonist Addition Significantly Impact Heroin Vaccine Efficacy
por: Bremer, Paul T., et al.
Publicado: (2014)

TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth Factors
por: Agrawal, Sudhanshu, et al.
Publicado: (2010)

Erratum to: TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth Factors
por: Agrawal, Sudhanshu, et al.
Publicado: (2010)

TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism
por: Noack, J, et al.
Publicado: (2012)

OMV Vaccines and the Role of TLR Agonists in Immune Response
por: Mancini, Francesca, et al.
Publicado: (2020)

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
por: Shen, Kuan-Yin, et al.
Publicado: (2020)

A novel defined TLR3 agonist as an effective vaccine adjuvant
por: Ko, Kwang Hyun, et al.
Publicado: (2023)

Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
por: Cascini, Caterina, et al.
Publicado: (2023)

Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists
por: Lacerte, Patricia, et al.
Publicado: (2016)

Protective Role of R-spondin1, an Intestinal Stem Cell Growth Factor, against Radiation-Induced Gastrointestinal Syndrome in Mice
por: Bhanja, Payel, et al.
Publicado: (2009)

The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma
por: Zhou, Zhimei, et al.
Publicado: (2021)

Non-Invasive Targeted Hepatic Irradiation and SPECT/CT Functional Imaging to Study Radiation-Induced Liver Damage in Small Animal Models
por: Kabarriti, Rafi, et al.
Publicado: (2019)

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
por: Luchner, Marina, et al.
Publicado: (2021)

A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms
por: Song, Ying-Chyi, et al.
Publicado: (2015)

Mode of action of maintenance immunotherapy therapy with the TLR-9 agonist MGN1703 in metastatic colorectal carcinoma: the Phase III IMPALA study
por: Stein, Alexander, et al.
Publicado: (2015)

Radiation therapy generates platelet-activating factor agonists
por: Sahu, Ravi P., et al.
Publicado: (2016)

Immunomodulation of prostate cancer cells after low energy focused ultrasound
por: Skalina, Karin, et al.
Publicado: (2015)

Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist
por: Volz, Barbara, et al.
Publicado: (2016)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Differential Adjuvant Activities of TLR7 and TLR9 Agonists Inversely Correlate with Nitric Oxide and PGE(2) Production
por: Lee, Jinhee, et al.
Publicado: (2015)

Low intensity focused ultrasound (LOFU) modulates unfolded protein response and sensitizes prostate cancer to 17AAG
por: Saha, Subhrajit, et al.
Publicado: (2014)

Intratumoral therapies and in-situ vaccination for melanoma
por: Huppert, Laura A., et al.
Publicado: (2022)

Autologous serum therapy in recalcitrant laser-assisted in situ keratomileusis-induced neurotrophic epitheliopathy
por: Lin, Shan-Jiun, et al.
Publicado: (2015)

TLR4 Agonist Monophosphoryl Lipid A Alleviated Radiation-Induced Intestinal Injury
por: Guo, Jiaming, et al.
Publicado: (2019)

TLR7/9 antagonist reduces HIV-1-induced immune activation
por: Chang, J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ihbdr2pf8tejl8pqjqb60sbsf7